Insulin Outlet Joins the Fight for Affordable Healthcare for All

January 27, 2025—As the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, Insulin Outlet is stepping up to help by providing safe, affordable, and accessible insulin to those who need it most. With stories of patients having to ration the drug or skip doses and, in a few cases, dying, Insulin Outlet offers a lifeline to those burdened by tough decisions. The Centers for Disease Control and Prevention (CDC) reported in 2024 that about 15.8% of all adults in the United States have diabetes.

“We are appalled that some diabetic patients are forced to potentially grapple with long-term health risks from unaffordable medical care,” said Hank Popeil, Insulin Outlet Public Relations Manager.

Insulin Outlet is proud to offer an alternative. By sourcing insulin from trusted international suppliers, the company ensures that diabetic patients can access high-quality medications at a fraction of the cost in the United States.

“Insulin Outlet is a lifeline for Americans struggling with the exorbitant cost of medication. By offering brand-name medications at significantly reduced prices, they provide a tangible solution to a critical healthcare system,” said Dr. Ari Magill. Magill has a medical degree from UT Southwestern Medical School in Dallas, Texas, and completed a residency in neurology at the University of Arizona in Tucson, Arizona.

“Our approach challenges the status quo, proving that quality care doesn’t have to come at an exorbitant cost. This isn’t just about medication—it’s about changing lives by removing barriers to essential health services,” Popeil said.

Insulin Outlet’s services are similar to those of neighborhood pharmacies. Patients must upload their prescriptions during the purchasing process to comply with federal regulations.

“We are not just providing insulin; we are providing hope,” said Popeil said. “Our team has worked to make sure there is a safe alternative.”

In the fall, the Federal Trade Commission (FTC) filed a lawsuit against the three largest pharmacy benefit managers (PBMs)—CVS Health’s Caremark, Cigna’s Express Scripts, and UnitedHealth’s Optum Rx—alleging they inflated insulin prices.

“While legislative efforts to address this crisis are ongoing, an immediate, viable alternative is procuring insulin internationally, with Canada being the most accessible option. In this context, Insulin Outlet offers an exemplary solution for U.S. patients, serving as a dependable and reputable source of insulin from Canada,” said Dr. Baran Erdik.

Erdik has served as a consultant for hospitals worldwide since graduating summa cum laude from Washington State University with a master’s degree in healthcare administration and policy.

“Our work is only the beginning. Together, we can create meaningful change and ensure that life-saving medications are accessible to all,” Popeil said.

About Insulin Outlet
Insulin Outlet is dedicated to making insulin safe, affordable, and accessible to diabetic patients across the United States. By implementing rigorous safety standards and partnering with trusted international suppliers, the company works to make high-quality insulin available to those who need it most.